Check our latest news and where we are going to be soon.
52º Congreso de la Sociedad Española de Nefrología
Oral communication C Jimenez, D Valencia , Mo Lopez, Me Gonzalez, Ma Moreno, A De Santos, A Ortega, T Diez, I Portero, A Sánchez-fructuoso. “Caracterización de los parámetros del Immunobiogram, un nuevo método para la medida in [...]
The TRANSBIO study demonstrates the usefulness of Immunobiogram® for predicting the response to different immunosuppressive treatments in transplant recipients
The results have been published in the high-impact journal Transplant immunology. TRANSBIO, a multicenter, international clinical study, has demonstrated the correlation of the in-vitro measurement of the patient's pharmacodynamic response to immunosuppressive drugs, using the Immunobiogram® diagnostic [...]
The CDTI awards Biohope one of the grants, funded by NextGenerationEU program, for companies distinguished with the European Seal of Excellence.
Biohope has been awarded one of the grants from the Center for the Development of Industrial Technology (CDTI), aimed at Spanish companies that have obtained the Seal of Excellence in the first call of the European Innovation [...]
Entrevista en Capital Radio: Biohope, la financiación de las Biotech y la búsqueda de fondos.
El lunes 23 de mayo de 2022, la Dra. Isabel Portero, CEO de Biohope, participó junto a Eva Martín Becerra, fundadora de Kinrel, en el programa Biotecnología Capital, de Capital Radio. Durante el programa, dirigido por [...]
Biohope celebra 7 años de hitos conseguidos y mira al futuro de la biotecnología española con optimismo
Durante los 7 años de vida de Biohope se han cumplido hitos científico-tecnológicos, regulatorios y comerciales de gran relevancia. El inminente lanzamiento del primer producto de Biohope y la consolidación del pipeline de proyectos conforman los principales retos [...]
BIOHOPE will participate as biotechnology presenting company in the Anglonordic Life Science Conference
The Anglonordic Life Science Conference is an exclusive event for European investors and R&D companies, mainly proceeding from the Nordics and the UK. Biohope has been selected by the Spanish Institute for Foreign Trade (ICEX) to participate, [...]
BIOHOPE will be part of the European Pavilion at BIO 2022
BIOHOPE has been selected by the European Innovation Council (EIC) as one of the 20 European biotech companies to participate at BIO International Convention 2022, the world's largest biotechnology exhibition. Under the framework of the EIC Overseas [...]
“El inversor europeo y las niñas deben apostar más por la biotecnología”
Los datos dicen que en España, faltan empresas que aporten alto valor añadido en la innovación, mujeres emprendedoras y vocación femenina por la ciencia. Isabel Portero, CEO de Biohope, habla sobre este tema en la entrevista [...]
The European Commission Awards a proposal from Biohope with The Seal of Excellence Certificate.
The Seal of Excellence Certificate is a quality label awarded by the Commission to projects by companies which have been assessed in a call for proposals under a Union instrument and comply with its quality requirements. The [...]
Dra. Isabel Portero included in the report “Referent Women in Innovative Entrepreneurship in Spain”
The report, based on surveys, has been done and coordinated by the High Commissioner of Entrepreneurship in Spain, which is an organism of the Government Presidency. This recognition reflects the role Dra. Portero is doing in [...]
